Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CBT Augmentation of SSRI Treatment for Geriatric GAD.

Trial Profile

CBT Augmentation of SSRI Treatment for Geriatric GAD.

Phase of Trial: Phase III

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Generalised anxiety disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 May 2013 Primary endpoint 'Penn-State-Worry-Questionnaire' has been met according to results published in the American Journal of Psychiatry.
    • 01 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Aug 2011 Planned end date changed from 1 Jul 2010 to 1 Sep 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top